Pumi Tong Pian (扑米酮片)扑米酮片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 上海信谊黄河制药有限公司Chinese legal name: 上海信谊黄河制药有限公司
主要成分Active Ingredients
- 塑料瓶装 每瓶Recorded Chinese composition: 塑料瓶装 每瓶
- 塑料瓶装Suliao Pingzhuang
- 每瓶Mei Ping
药物知识说明
塑料瓶装 每瓶是一种在国家药监局注册认定的药品。该药品含有塑料瓶装、塑料瓶装 每瓶、每瓶-08525046等成分。
该药品关联的活性成分包括:塑料瓶装Suliao Pingzhuang、塑料瓶装 每瓶Recorded Chinese composition: 塑料瓶装 每瓶、每瓶。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为:上海信谊黄河制药有限公司Chinese legal name: 上海信谊黄河制药有限公司。
您可以探索含有相同成分的其他药品:塑料瓶装-aede4179成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 扑米酮片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 塑料瓶装Suliao Pingzhuang, 塑料瓶装 每瓶Recorded Chinese composition: Recorded Chinese name: 塑料瓶装 Recorded Chinese name: 每瓶.
Manufacturers recorded for this product: 上海信谊黄河制药有限公司Chinese legal name: 上海信谊黄河制药有限公司.
Explore other medicines containing the same ingredient: 塑料瓶装 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 扑米酮片Recorded Chinese name: 扑米酮片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 250毫克×100片250 mg × 100 tablets
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 上海信谊黄河制药有限公司Chinese legal name: 上海信谊黄河制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H31020145
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H31020145
Manufacturer
Chinese legal name: 上海信谊黄河制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H31020145
生产企业
上海信谊黄河制药有限公司(国产)
适应症
本品用于癫、强直阵挛性发作(大发作),单纯部分性发作和复杂部分性发作的单药或联合用药治疗。也用于特发性震颤和老年性震颤的治疗。
用法用量
口服给药、成人常用量50mg开始,睡前服用,3日后改为每日2次,一周后改为每日3次,第10日开始改为250mg,每日3次,总量不超过每日1.5g;维持量一般为250mg,每日3次。小儿常用量1.8岁以下,每日睡前服50mg;3日后增加为每次50mg,每日2次;一周后改为100mg,每日2次;10日后根据情况可以增加至125~250mg,每日3次;或每日按体重10~25mg/kg分次服用。2.8岁以上同成人。
不良反应
1.患者不能耐受或服用过量可产生视力改变,复视,眼球震颤,共济失调,认识迟钝,情感障碍,精神错乱,呼吸短促或障碍。2.少见的有儿童和老人者为异常的兴奋或不安等反常反应。3.偶见有过敏反应(呼吸困难,眼睑肿胀,喘鸣或胸部紧迫感),粒细胞减少,再障、红细胞发育不良,巨细胞性贫血。4.发生手脚不灵活或引起行走不稳、关节孪缩,眩晕、嗜睡。少数患者出现性功能减退、头痛、食欲不振,疲劳感,恶心或呕吐,但继续服用往往会减轻或消失。可出现中毒性表皮坏死。
禁忌
尚不明确。
注意事项
1.下列情况慎用:(1)肝肾功能不全者(可能引起本品在体内的积蓄)。(2)有卟啉病者(可引起新的发作)。(3)哮喘、肺气肿或其他可能加重呼吸困难或气道不畅等呼吸系统疾患。(4)可引起轻微脑功能障碍的病情加重。2.对巴比妥类过敏者对本品也可能过敏。3.对诊断的干扰:血清胆红素可能降低,酚妥拉明试验可出现假阳性,如需作此试验需停药至少24小时,最好48~72小时。4.个体间血药浓度差异很大,用药需个体化。5.停药时用量应递减,防止重新发作。6.治疗期间需按时服药,发现漏服应尽快补服,但距下次给药前1小时内则不必补服,勿一次服用双倍量。7.用药期间应注意检查血细胞计数,定期测定扑米酮及其代谢产物苯巴比妥的血药浓度。
规格
250毫克×100片
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.